The hormonal response to intravenous 5-hydroxytryptophan in bulimia nervosa

Journal of Psychosomatic Research

Volumn 40, Issue 3, 1996, Pages 289-297

  Goldbloom, David S ^a   Garfinkel, Paul E ^b   Katz, Randy ^b   Brown, Gregory M ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b NONE

Author keywords

5 hydroxytryptophan; Bulimia nervosa; Eating disorders; Neuroendocrine; Prolactin; Serotonin

Indexed keywords

5 HYDROXYTRYPTOPHAN; GROWTH HORMONE; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; BULIMIA; CONTROLLED STUDY; FEEDING DISORDER; FEMALE; HORMONE RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION;

EID: 0029988393     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-3999(95)00640-0     Document Type: Article

References (52)

1. RUSSELL GFM. Bulimia nervosa: an ominous variant of anorexia nervosa. Psychol Med 1979; 9: 429-448.
2. HUDSON JI, POPE HG (Eds). The Psychobiology of Bulimia. New York: American Psychiatric Press, 1987.
3. PIRKE KM, VANDEREYKEN W, PLOOG D (Eds). The Psychobiology of Bulimia Nervosa. Berlin: Springer-Verlag, 1988.
4. JOHNSON C, CONNORS ME (Eds). The Etiology and Treatment of Bulimia Nervosa: A Biopsychosocial Perspective. New York: Basic Books, 1987.
5. GOLDBLOOM DS, GARFINKEL PE. The serotonin hypothesis of bulimia nervosa: theory and evidence. Can J Psychiatry 1990; 35: 741-744.
6. BREWERTON TD, MUELLER EA, LESEM MD, BRANDT HA, QUEARRY B, GE ORGE DT, MURPHY DL, JIMERSON DC. Neuroendocrine responses to m-chlorophenylpiperazine and l-tryptophan in bulimia. Arch Gen Psychiatry 1992; 49: 852-861.
7. LEIBOWITZ SF, SHOR-POSNER G. Brain serotonin and eating behaviour. Appetite 1986; 7 (Suppl): 1-14.
8. WURTMAN RJ, WURTMAN JJ. Carbohydrate craving, obesity, and brain serotonin. Appetite 1986; 7 (Suppl): 99-103.
9. WALSH BT, KISSILEFF HR, CASSIDY SM, DANTZIC S. Eating behaviour in women with bulimia. Arch Gen Psychiatry 1989; 46: 54-58.
10. GERACIOTI TD, LIDDLE RA. Impaired cholecystokinin secretion in bulimia nervosa. New Engl J Med 1988; 319: 683-688.
11. GOODWIN GM, FRASER S, STUMP K, FAIRBURN CG, ELLIOTT JM, COWEN P. Dieting and weight loss in volunteers increases the number of alpha-2-adrenoreceptors and 5-HT receptors on blood platelets without effect on 3-H-imipramine binding. J Affective Disord 1987a; 12: 267-274.
12. GOODWIN GM, FAIRBURN CG, COWEN PJ. Dieting changes serotonergic function in women, not men: implications for the aetiology of anorexia nervosa? Psychol Med 1987b; 17: 839-842.
13. VAN PRAAG HM, KAHN RS, ASNIS GM, WETZLER S, BROWN SL, BLEICH A, KORN ML. Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affective Disord 1987; 13: 1-8.
14. COCCARO EF, SIEVER LJ, KLAR HM, MAURER G, COCHRANE K, COOPER TB, MOHS RC, DAVIS KL. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behaviour. Arch Gen Psychiatry 1989; 46: 587-599.
15. MCBRIDE WJ, MURPHY JM, LUMENG L, LI TK. Serotonin and alcohol preference. In Recent Developments in Alcoholism, Vol. 7 (Edited by Galanter M) pp. 187-209. New York: Plenum Press, 1989.
16. AFTER A, VAN PRAAG HM, PLUTCHIK R, SEVY S, KORN M, BROWN SL. Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res 1990; 32: 191-199.
17. LACEY JH, EVANS CDH. The impulsivist: a multi-impulsive personality disorder. Br J Addict 1986; 81: 641-649.
18. KECK PE, POPE HG, HUDSON JI, McELROY SL, YURGELUN-TODD D, HUNDERT EM. A controlled study of phenomenology and family history in outpatients with bulimia nervosa. Compr Psychiatry 1990; 31: 275-283.
19. KASSETT JA, GERSHON ES, MAXWELL ME, GUROFF JJ, KAZUBA DM, SMITH AL, BRANDT HA, JIMERSON DC. Psychiatric disorders in the first-degree relatives of probands with bulimia nervosa. Am J Psychiatry 1989; 146: 1468-1471.
20. KAYE WH, EBERT MH, GWIRTSMAN HE, WEISS SR. Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia. Am J Psychiatry 1984; 141: 1598-1604.
21. JIMERSON DC, LESEM MD, KAYE WH, BREWERTON TD. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 1992; 49: 132-138.
22. GOLDBLOOM DS, HICKS LK, GARFINKEL PE. Platelet serotonin uptake in bulimia nervosa. Biol Psychiatry 1990; 28: 644-647.
23. KAYE WH, GWIRTSMAN HE, BREWERTON TD, GEORGE DT, WURTMAN RJ. Bingeing behaviour and plasma amino acids: a possible involvement of brain serotonin in bulimia nervosa. Psychiatry Res 1988; 23: 31-43.
24. FLUOXETINE BULIMIA NERVOSA COLLABORATIVE STUDY GROUP. Fluoxetine in the treatment of bulimia nervosa. Arch Gen Psychiatry 1992; 49 139-147.
25. BLOUIN AG, BLOUIN JH, PEREZ EL, BUSHNIK T, ZURO C, MULDER E. Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 1988; 8: 261-269.
26. POPE HG, KECK PE, MCELROY SL, HUDSON JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989; 9: 254-259.
27. MELTZER HY, UMBERKOMAN-WIITA B, ROBERTSON A, TRICOU BJ, LOWY M, PERLINE R. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. Arch Gen Psychiatry 1984; 41: 366-374.
28. VAN DE KAR LD. Neuroendocrine aspects of the serotonergic hypothesis of depression. Neurosci Biobehav Rev 1989; 13: 237-246.
29. CHARNEY DS, HENINGER GR. Serotonin function in panic disorder. Arch Gen Psychiatry 1986; 43: 1059-1065.
30. DEN BOER JA, WESTENBERG HGM. Behavioural, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder. Psychiatry Res 1990; 31: 267-278.
31. FICHTER MM, PIRKE KM, HOLSBOER F. Weight loss causes neuroendocrine disturbances: experimental study in healthy starving subjects. Psychiatry Res 1986; 17: 61-72.
32. ANDERSON IM, PARRY-BILLINGS M, NEWSHOLME EA, FAIRBURN CG, COWEN PJ. Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med 1990; 20: 785-791.
33. TUOMISTO J, MANNISTO P. Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 1985; 37: 249-332.
34. Diagnostic and Statistical Manual of Mental Disorders, Third Edn, Rev. pp. 67-69. Washington, DC: American Psychiatric Association, 1987.
35. ROBINS LN, HELZER JE, CROUGHAN J, RATCLIFF KS. National Institute of Mental Health Diagnostic Interview Schedule. Arch Gen Psychiatry 1981; 38: 381-389.
36. GARNER DM, GARFINKEL PE. The eating attitude test: an index of the symptoms of anorexia nervosa. Psychol Med 1979; 9: 273-279.
37. GARNER DM, OLMSTED MP, POLIVY J. Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eating Disord 1983; 2: 15-34.
38. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
39. HORITA A, HAMILTON AE. Potentiation of the central actions of 5-hydroxytryptophan in rabbits by DL-alpha-hydrazine-alpha-methyldopa. J Pharm Pharmacol 1970; 22: 389-391.
40. SUELDO CE, DUDA M, KLETSKY OA. Influence of sequential doses of 5-hydroxytryptophan on prolactin response. Am J Obstet Gynecol 1986; 154: 424-427.
41. HWANG P, GUYDA H, FRIESEN H. A radioimmunoassay for human prolactin. Proc Natl Acad Sci USA 1971; 68: 1902-1906.
42. SCHALCH DS, PARKER ML. Double antibody radioimmunoassay for growth hormone. Nature 1964; 203: 1141-1142.
43. BROWN GM, GROTA LJ, PENNEY DP, REICHLIN S. Pituitary-adrenal function in the squirrel monkey. Endocrinology 1970; 86: 519-529.
44. ANDERSON GM, PURDY WC. Liquid-chromatographic-fluorometric system for the determination of indoles in physiological samples. Anal Biochem 1979; 51: 283-286.
45. COPELAND PM, HERZOG DB, CARR DB, KLIBANSKI A, MACLAUGHLIN RA, MARTIN JB. Effect of dexamethasone on cortisol and prolactin responses to meals in bulimic and normal women. Psychoneuroendocrinology 1988; 13: 273-278.
46. MORTOLA JF, RASMUSSEN DD, YEN SC. Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: evidence for a central mechanism. J Clin Endocrinol Metabol 1989; 68: 517-522.
47. WELTZIN TE, McCONAHA C, McKEE M, HSU LKG, PEREL J, KAYE WH. Circadian patterns of cortisol, prolactin, and growth hormonal secretion during bingeing and vomiting in normal weight bulimic patients. Biol Psychiatry 1991; 30: 37-48.
48. VAN PRAAG HM, LEMUS C, KAHN R. Hormonal probes of central serotonergic activity: do they really exist? Biol Psychiatry 1987; 22: 86-98.
49. YATHAM LM, STEINER M. Neuroendocrine probes of serotonergic function: a critical review. Life Sci 1993; 53: 447-463.
50. VAN PRAAG HM. In search of the mode of action of antidepressants: 5-HTP/tyrosine mixtures in depression. Neuropharmacology 1983; 22: 433-440.
51. AGREN H, REIBRING L, HARTVIG P, TEDROFF J, BJURLING P, HORNFELDT K, ANDERSSON Y, LUNDQVIST H, LANGSTROM B. Low brain uptake of L-11-C-5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers. Acta Psychiatr Scand 1991; 83: 449-455.
52. GARTSIDE SE, COWEN PJ, SHARP T. Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 1992; 31: 9-14.